2022
DOI: 10.1016/j.anndiagpath.2021.151865
|View full text |Cite
|
Sign up to set email alerts
|

Specialized pro-resolving receptors are expressed in salivary glands with Sjögren's syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 126 publications
1
4
0
Order By: Relevance
“…This accords with the finding of FPR2/ALX expression in human dermal epithelium [7]. Other epithelial cells expressing FPR2/ALX include ductal and acinar cells in human minor salivary glands [26][27][28], as well as cultured human submandibular gland cells [26]. In cultured oral epithelial cells, qRT-PCR showed transcription of FPR2/ALX and flow cytometry showed that the receptor was present on both the cell surface and within the cytoplasm.…”
Section: Discussionsupporting
confidence: 88%
“…This accords with the finding of FPR2/ALX expression in human dermal epithelium [7]. Other epithelial cells expressing FPR2/ALX include ductal and acinar cells in human minor salivary glands [26][27][28], as well as cultured human submandibular gland cells [26]. In cultured oral epithelial cells, qRT-PCR showed transcription of FPR2/ALX and flow cytometry showed that the receptor was present on both the cell surface and within the cytoplasm.…”
Section: Discussionsupporting
confidence: 88%
“…RvD1, 17R-RvD1, RvD3, 17R-RvD3, RvD5, RvE1, and 18S-RvE1 can combine with the G protein-coupled receptor (GPR32) expressed in monocyte-macrophages, lymphocytes, endothelial cells, and vascular smooth muscle cells, while GPR18/DRV2 is a novel discovered receptor of RvD2 expressed in macrophages, neutrophils, and monocytes [ 55 , 56 ]. In addition, RvD1, 17R-RvD1, and RvD3 can also combine with the G protein-coupled formyl peptide receptor 2 (ALX/FPR2) to produce anti-inflammatory effects [ 57 , 58 , 59 ]. Leukotriene B4 receptor 1 (BLT1) expressed in lymphocytes and leukocytes and ChemR23 expressed in NK cells, macrophages, epithelial cells, and dendritic cells have been proven to be the receptors of RvE1, 18S-RvE1, and RvE2 through target screening [ 60 , 61 ].…”
Section: Resolvins Receptorsmentioning
confidence: 99%
“…However, when this mechanism is abnormal, dead cells are not cleared in time, leading to the formation of their antigens, increased levels of cytokines and chemokines, and lymphocyte infiltration ( 155 ). Specific pro-resolving mediators (SPMs, including liposomes, resolvins, marisins, and protectin) and their aspirin-triggered (AT) forms act as inflammatory mediators, promoting tissue regeneration by limiting uncontrolled inflammation while promoting its termination ( 156 ). Odusanwo et al.…”
Section: Regulation Of the Immune Microenvironmentmentioning
confidence: 99%
“…Resolvins are special proresolving mediators (SPMs) that can actively regulate inflammation. Furthermore, the expression of various SPM receptors (ALX/FPR2, BLT1, and CMKLR1) was found in human salivary glands, which may be a potential target for treating pSS patients ( 156 ).…”
Section: Treatmentmentioning
confidence: 99%